Amanda Peppercorn
GlaxoSmithKline (United States)(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, HIV/AIDS drug development and treatment, Respiratory viral infections research, HIV Research and Treatment
Most-Cited Works
- → Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19(2022)289 cited
- → Safety, Tolerability, and Pharmacokinetics of the HIV Integrase Inhibitor Dolutegravir Given Twice Daily With Rifampin or Once Daily With Rifabutin(2012)191 cited
- → A phase 1 study to evaluate the effect of dolutegravir on renal function via measurement of iohexol and para‐aminohippurate clearance in healthy subjects(2012)186 cited
- → Effect of Food on the Pharmacokinetics of the Integrase Inhibitor Dolutegravir(2011)111 cited
- → Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trial(2017)103 cited
- → In vivo induced antigen technology (IVIAT)(2004)87 cited
- → Pharmacokinetics of the HIV integrase inhibitor S/GSK1349572 co-administered with acid-reducing agents and multivitamins in healthy volunteers(2011)82 cited
- → Identification of In Vivo-Induced Bacterial Protein Antigens during Human Infection with Salmonella enterica Serovar Typhi(2006)74 cited
- → Preventing healthcare-associatedAspergillusinfections: review of recent CDC/HICPAC recommendations(2009)66 cited
- → Effect of atazanavir and atazanavir/ritonavir on the pharmacokinetics of the next‐generation HIV integrase inhibitor, S/GSK1349572(2011)65 cited